$AXNX Axonics® to Participate in September Investor Conferences
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock
Time:
4:34 PM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® Announces Pricing of Public Offering of Common Stock
Time:
11:13 PM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® Announces Proposed Public Offering of Common Stock
Time:
4:11 PM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® Reports Second Quarter 2022 Financial Results
Time:
4:01 PM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® to Report Second Quarter 2022 Financial Results on August 1
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire
$AXNX Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® to Report First Quarter 2022 Financial Results on May 5
Time:
4:01 PM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® Launches Direct to Consumer Television Advertising Campaign
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System
Time:
4:01 PM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® to Participate in SVB Leerink Virtual Healthcare Conference
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX New Study Finds More Than 60% of Adult Women in the U.S. Experience Urinary Incontinence
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical Council
on November 30, 2021
News
and Tags: AXNX, AXNX News, Axonics Inc., Axonics Inc. News
with 0 comments
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
on November 17, 2021
News
and Tags: AXNX, AXNX News, Axonics Inc., Axonics Inc. News
with 0 comments
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® Reports Third Quarter 2021 Financial Results
Time:
4:01 PM
Symbol:
AXNX
Source:
Business Wire News Releases
$AXNX Axonics® Ranked the Fastest Growing Publicly Traded Company in Orange County
Time:
6:00 AM
Symbol:
AXNX
Source:
Business Wire News Releases
12